Page 101

Febrero 2017

ARTÍCULO ESPECIAL 237 15. Beck JC, McGarry EE. Physiological importance of cortisol. Br Med Bull 1962; 18 (2): 134-40. 16. Bryth BC, Billinsley GD, Cox DW. Physical and genetic mapping of the serpin gene cluster at 14q32.1: allelic assocaition and a unique haplotype assocaited with alpha 1-antitrypsin deficiency. Am J Hum Genet 1994; 55 (1): 126-33. 17. Lin HY, Muller YA, Hammond GL. Molecular and structural basis of steroid hormone binding and release from corticosteroid-binding globulin. Mol Cell Endocrinol 2010; 316 (1): 3-12. 18. Harper ME, Dugaiczyk A. Linkage of the evolucionarily related serum albumin and alpha-fetoprotein genes within q11-22 of human chromosome 4. Am J Human Genete 1983; 35: 565-72. 19. Keenan DM, Roelfsema FR, Veldhuis JD. Endogenous ACTH concentration-dependent drive of cortisol secretion in the human. Am J Physiol Endocrinol Metab 2004; 287: 652-61. 20. Lewis JG, Bagley CJ, Elder PA, Bachman AW, Torpy DJ. Plasma free cortisol fractional reflects levels of functioning corticosteroid-binding globulina. Clin Chim Acta 2005; 359: 189-94. 21. Hamrahian AH, Oseni TA, Arafah BM. Measurements of serum free cortisol in critically ill patients. N Engl J Med 2004; 350: 1629-38. 22. Loriaux L. Glucocorticoid therapy in the intensive care unit. NEJM 2004; 350: 1601-2. 23. Lewis JG, Elder PA. The reactive centre loop of corticosteroid binding globulin (CBG) is a protease target for cortisol release. Mol Cell Endocrinol 2014; 384 (1-2): 96-101. 24. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 1985; 318: 635-41. 25. Encio IJ, Detera-Wadleigh SD. The genomic structure of the human glucocorticoid receptor. J Biol Chem 1991; 266: 7182-8. 26. Lu NZ, Cidlowski JA. Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol Cell 2005; 18: 331-42. 27. Bamberger CM, Bamberger AM, de Castro M, Chrousos GP. Glucocorticoid receptor beta, a potencial endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 1995; 95: 2435-41. 28. Oakley RH, Jewell CM, Yudt MR, Bofetiado DM, Cidlowski JA. The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanism of action. J Biol Chem 1999; 274: 27857-66. 29. Webster JC, Oakley RH, Jewell CM, Cidlowski JA. Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proc Natl Acad Sci USA 2001; 98: 6865-70. 30. Lewis-Tuffin LJ, Cidlowski JA. The physiology human glucocorticoid receptor beta (hGRbeta) and glucocorticoid resistance. Ann N Y Acad sci 2006; 1069: 1-9. 31. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM. Cloning of human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor.  Science 1987; 237: 268-75. 32. Fardella CE, Miller WL. Molecular biology of mineralocorticoid metabolism. Annu Rev Nutr 1996; 16: 443-70. 33. White PC. Inherited forms of mineralocorticoid hypertension.  Hypertension 1996; 28: 927-36. 34. Stewart PM, Whorwood CB, Mason JI. Type 2 11 beta hydroxysteroid dehydorgenase in foetal and adult life. J Steroid Biochem Mol Biol 1995; 55: 465-71. 35. Chrousos GP, Detera-Wadleigh SD, Karl M. Syndrome of glucocorticoid resistance. Ann Inter Med 1993; 119: 1113- 24. 36. van Rossum EF, van den Akker EL. Glucocorticoid resistance. Endocr Dev 2011; 20: 127-36. 37. Annane D, Sebille V, Troche G, Raphael JC, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283:1038-45. 38. Sibbald WJ, Short A, Cohen MP, Wilson RF. Variations in adrenocortical responsiveness during severe bacterial infections. Unrecognized adrenocortical insufficiency in severe bacterial infections. Ann Surg 1977; 186: 29-33. 39. Rothwell PM, Udwadia ZF, Lawler PG. Cortisol response to corticotropin and survival in septic shock. Lancet 1991; 337: 582-3. 40. Soni A, Pepper GM, Wyrwinski PM, Ramírez NE, Simon R, Pina T, et al. Adrenal insufficiency occurring during septic shock: incidence, outcome, and relationship to peripheral cytokine levels. Am J Med 1995; 98: 266-71. 41. Briegel J, Schelling G, Haller M, Mraz W, Forst H, Peter K. A comparison of the adrenocortical response during septic shock and after complete recovery. Intensive Care Med 1996; 22: 894-9. 42. Oppert M, Schindler R, Husung C, Offermann K, Gräf KJ, Boenisch O, et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 2005; 33: 2457-64. Cortisol en estrés agudo - J. Guerrero Rev Med Chile 2017; 145: 230-239


Febrero 2017
To see the actual publication please follow the link above